Management of symptomatic intracranial atherosclerotic disease

Tudor G Jovin1, Rishi Gupta, Michael B Horowitz

  • 1University of Pittsburgh Medical Center, Stroke Institute, 200 Lothrop Street, Suite C-400, Pittsburgh, PA 15213, USA. jovintg@upmc.edu

Insights

Symptomatic intracranial stenosis indicates aggressive vascular disease. While medical therapy is standard, high-risk patients may benefit from endovascular treatment, though further trials are needed.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • Symptomatic intracranial stenosis is linked to a high risk of recurrent stroke (approx. 10% per year) and mortality.
  • It signifies aggressive vascular disease, often accompanied by comorbidities.
  • Medical management, including risk factor control and antiplatelet therapy, is the primary treatment.

Purpose of the Study:

  • To review medical treatment options for symptomatic intracranial stenosis.
  • To outline the current status of endovascular therapies for this condition.

Main Methods:

  • Review of prospective studies on symptomatic intracranial stenosis.
  • Analysis of medical treatment strategies.
  • Evaluation of endovascular treatment advancements (angioplasty and stenting).

Main Results:

  • Certain high-risk patients with severe stenosis (>70%) and hemodynamic impairment may not respond to medical therapy.
  • Advances in angioplasty and stenting technologies now allow for endovascular consideration in these refractory cases.
  • The comparative benefit of endovascular therapy versus medical therapy for high-risk patients remains to be established in randomized trials.

Conclusions:

  • Symptomatic intracranial stenosis requires aggressive management due to its association with poor outcomes.
  • Endovascular treatment is a potential option for select high-risk patients refractory to medical therapy.
  • Further randomized clinical trials are essential to establish the efficacy of endovascular interventions.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...